Has Ivette Cardona Ruelle received payments from drug or device companies?

Yes. Drug and device makers reported $4,153 in general payments to Ivette Cardona Ruelle across 131 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ivette Cardona Ruelle did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ivette Cardona Ruelle come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ivette Cardona Ruelle

General Practice · Tampa, FLNPI 1356516827

Payments from drug & device makers

$4,153in general payments, 2019–2025

Across 131 payments — averaging $31.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$841
Abbott$655
AbbVie$505
Amgen$462
Novo Nordisk$376
Lilly USA, LLC$341
plus $973 from 11 others

What the payments were for

Food & beverage$3,86793%
Education$120%
Other$2757%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	18	$841
Abbott	9	$655
AbbVie	14	$505
Amgen	12	$462
Novo Nordisk	12	$376
Lilly USA, LLC	20	$341
GSK	10	$231
Phathom Pharmaceuticals, Inc.	1	$125
Bayer	7	$124
Amarin Pharma, Inc.	7	$116
Pfizer	7	$114
Boehringer Ingelheim	4	$83
Biohaven Pharmaceutical Holding Company Ltd.	3	$57
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$35
Exact Sciences	2	$32
Philips North America LLC	2	$29
Angiodynamics, Inc.	1	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,153 in reported general payments places this provider in the 90th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	45	$50,806
JardianceEmpagliflozin	30	$45,500
EntrestoSacubitril/Valsartan	23	$26,634
JanuviaSitagliptin Phosphate	16	$22,889
XareltoRivaroxaban	27	$21,001
SymbicortBudesonide/Formoterol Fumarate	35	$11,518
LantusInsulin Glargine,hum.Rec.Anlog	20	$3,198
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	19	$2,773
Levothyroxine Sodium	261	$2,519
Losartan Potassium	257	$2,304
Atorvastatin Calcium	322	$2,222
Glipizide	98	$1,434
Albuterol Sulfate HfaAlbuterol Sulfate	40	$1,390
Metoprolol Succinate	115	$1,287
Rosuvastatin Calcium	216	$1,230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$114	$50,80645 claims
Boehringer IngelheimJardiance	$83	$45,50030 claims
AstraZenecaSymbicort	$841	$11,51835 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,901 general practice providers in Florida.

Other general practice in Tampa

Arnaldo Orellana MolinaTampa$2.5M
Robert HannumTampa$1.8M
Osvanny NodalTampa$1.1M
Jose CardonaMiami$71M
Lawrence GalitzMiami Gardens$42.5M
Armando AcevedoMiami$15.2M
Jorge AmayaMiami$14.2M
Frank AlvarezHialeah$13.6M
Hector RodriguezMiami$12.8M
Eddie ArmasSouth Miami$12.4M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →